Insertional inactivation of the gene for the meningococcal lactoferrin binding protein

M L Quinn1, S J Weyer, L A Lewis

  • 1Department of Microbiology and Immunology, State University of New York at Buffalo 14214, USA.

Microbial Pathogenesis
|October 1, 1994
PubMed

Insights

Neisseria meningitidis lactoferrin binding protein (LBP) is essential for binding human lactoferrin (LF) and acquiring iron. Mutating the LBP gene confirmed its role as the primary meningococcal receptor for LF.

Area of Science:

  • Microbiology
  • Bacterial Pathogenesis
  • Outer Membrane Proteins

Background:

  • Neisseria meningitidis requires iron for growth and survival.
  • Human lactoferrin (LF) is an iron-binding protein present in mucosal secretions.
  • The lactoferrin binding protein (LBP) was hypothesized to be the meningococcal receptor for LF.

Purpose of the Study:

  • To genetically confirm the function of the lactoferrin binding protein (LBP) in Neisseria meningitidis.
  • To elucidate the role of LBP in lactoferrin binding and iron acquisition.

Main Methods:

  • Isolation of a clone encoding LBP using an oligonucleotide probe derived from N-terminal amino acid sequence.
  • Shuttle mutagenesis of the LBP gene using an erythromycin mini-transposon.
  • Introduction of the transposon insertion into N. meningitidis.
  • Analysis of LBP expression, LF binding, and iron utilization in the mutant strain.

Main Results:

  • A transposon insertion successfully disrupted the LBP coding sequence in N. meningitidis.
  • The LBP-deficient mutant failed to produce the 105 kDa outer membrane protein.
  • The mutant strain exhibited a complete inability to bind human lactoferrin (LF).
  • The LBP mutant could not utilize LF as an iron source for growth.
  • No other significant alterations in membrane protein profiles were observed in the mutant.

Conclusions:

  • Lactoferrin binding protein (LBP) is definitively confirmed as the meningococcal receptor for human lactoferrin.
  • LBP plays a critical role in Neisseria meningitidis's ability to acquire iron from lactoferrin.
  • Targeting LBP could represent a novel strategy for combating meningococcal infections.